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cEstimation of volume status is a critical component
in the care of patients with heart failure. Such
assessments are used on a routine basis to guide
therapeutic decision making, including adjustment
of diuretics, whether to initiate or uptitrate beta-
adrenergic blockers, and whether to hospitalize a
patient. Traditionally, the cornerstone of volume
assessment has been the history and physical exam-
ination, but there are concerns regarding its accu-
racy. Thus, a variety of additional techniques for
assessing volume status have been tested, including
measurement of biomarkers (e.g., natriuretic pep-
tide levels) and performance of imaging studies
(e.g., echocardiography).
See page 16
In this issue of iJACC, Pellicori et al. (1) provide
an important contribution to the literature. In their
study of nearly 700 patients (568 with heart failure)
evaluated in a “specialist community clinic” in the
United Kingdom, the maximal diameter of the
inferior vena cava (IVCmax) at approximately 3 cm
from the right atrium was measured by echocardi-
ography. The study’s noteworthy findings included
that IVCmax was a reproducible measurement; there
was a broad distribution of IVCmax among patients
with heart failure; IVCmax was correlated with
natriuretic peptide levels and clinical markers of
congestion including the jugular venous pressure
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UT Southwestern Medical Center.JVP); and an increased IVCmax was independently
ssociated with the composite endpoint of heart
ailure hospital admission and cardiovascular
eath, as well as overall mortality, in multivari-
ble models that were adjusted for other risk
actors including N-terminal pro–B-type natri-
retic peptide (NT-proBNP) level. This is the
rst large study of patients with heart failure to
emonstrate that IVC assessed by echocardiog-
aphy has powerful prognostic utility, and the
nvestigators are to be congratulated for moving
he field forward.
mportance of IVC and right atrial pressure in left heart
ailure. The rationale for measuring the IVC in left
eart failure is that IVC distention is related to an
ncreased right atrial pressure (RAP) (2), and sev-
ral lines of evidence demonstrate that elevated
AP is an adverse risk factor in left heart failure.
irst, elevated JVP, reflecting elevated RAP, was
ndependently associated with the risk of hospital-
zation and death from pump failure in the SOLVD
Studies of Left Ventricular Dysfunction) treatment
rial (3). Second, in patients with left ventricular
LV) systolic heart failure, a reduced right ventric-
lar ejection fraction (which ultimately would result
n an elevated RAP) is a risk factor for mortality
4,5). Third, RAP often mirrors LV filling pressure
n chronic heart failure, whether the LV ejection
raction is reduced (6–8) or preserved (9), and
levated LV filling pressure has been shown to be
ssociated with adverse outcomes in patients with
dvanced heart failure (10).
ow best to estimate RAP in heart failure? In prior
tudies (2,11,12), the maximal diameter of IVC,
hich is the method used in the current study (1),
orrelated modestly with RAP with correlation
oefficients between these 2 parameters ranging
rom r  0.48 (2) to r  0.56 (12). IVC collaps-
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30ibility with inspiration was shown to more accu-
rately measure RAP as compared with IVCmax (2),
lthough combining both approaches may be pref-
rable (11). Three-dimensional echocardiographic
easurement of right atrial volume has also been
hown to have utility in assessing RAP (12).
It is also important to consider whether echocar-
iographic measurement of IVCmax is more useful
han clinical examination of the jugular veins for
stimation of RAP. Although the investigators
tated that the RAP “evaluation by physical exam-
nation is unreliable” (1), by receiver-operating
haracteristic analysis the area under the curve
AUC) for clinical estimation of RAP12 mm Hg
n the ESCAPE (Evaluation Study of Congestive
eart Failure and Pulmonary Artery Catheteriza-
ion Effectiveness) trial was 0.74 (13), which is very
imilar to the published AUC for estimating RAP
y ultrasound (0.76) (11,12). In the current study,
he methodology for IVCmax measurement was
igorous, but less information was provided con-
erning the evaluation of the JVP. The categories
sed to assess the jugular veins were described (“not
isible, raised 1 to 4 cm, raised to earlobe”), but such
ategories would reflect drastically different RAPs
epending upon the angle at which the patients lay
uring examination (e.g., jugular venous distention
o the earlobe is very different if a patient is supine
r upright). Further, it was not reported who
erformed the physical examination nor how expe-
ienced they were in assessing the JVP. Unfortu-
ately, in my observation, lack of such details
egarding the methodology of the clinical evalua-
ion is not uncommon in the published literatureMJ, Dec GW. Preserved right ven- Transplant 2012;31:he investigation, but one which should be consid-
red when assessing studies that purport to demon-
trate that a new technique (whether it is a bio-
arker or an imaging technique) is superior to the
istory and physical examination.
Where do we go from here? The time has come to
ssess whether routine incorporation of hand-
arried echocardiography to assess filling pressures
an improve clinical outcomes of patients with heart
ailure as compared with therapy based upon a
arefully performed history and physical examina-
ion. An evidence base for such a trial is beginning
o emerge. In a study in which hand-carried echo-
ardiography, BNP levels, and clinical evaluation
ere used to estimate elevated LV filling pressures
pulmonary capillary wedge pressure 15 mm Hg)
n patients with chronic systolic heart failure, IVCmax
had the highest AUC (0.89) followed by BNP
levels (0.88), evaluation of JVP (0.82), and a clinical
congestion score (0.74) (14). Importantly, the com-
bination of these parameters had better operating
characteristics (AUC 0.97) than any individual test,
highlighting the potential utility of combining
hand-carried echocardiography with the traditional
history and physical examination. The important
study by Pellicori et al. (1) provides further impetus
to move toward such a clinical trial and emphasizes
that IVC measurement should be included in such
an endeavor.
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